D. Clemmons, Value of Insulin-like Growth Factor System Markers in the Assessment of Growth Hormone Status, Endocrinology and Metabolism Clinics of North America, vol.36, issue.1, pp.109-129, 2007.
DOI : 10.1016/j.ecl.2006.11.008

L. Katznelson, E. Laws, J. Melmed, S. Molitch, M. Murad et al., Acromegaly: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.11, pp.3933-3951, 2014.
DOI : 10.1210/jc.2014-2700
URL : https://academic.oup.com/jcem/article-pdf/99/11/3933/10905534/jcem3933.pdf

A. Giustina, P. Chanson, D. Kleinberg, M. Bronstein, D. Clemmons et al., Expert consensus document: A consensus on the medical treatment of acromegaly, Nature Reviews Endocrinology, vol.161, issue.4, pp.243-248, 2014.
DOI : 10.1530/EJE-09-0389

M. Molitch, D. Clemmons, S. Malozowski, G. Merriam, M. Vance et al., Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice, Clin Endocrinol (Oxf), vol.67, pp.65-70, 2007.

A. Krebs, H. Wallaschofski, E. Spilcke-liss, T. Kohlmann, G. Brabant et al., Five commercially available insulin-like growth factor I (IGF-I) assays in comparison to the former Nichols Advantage IGF-I in a growth hormone treated population, Clinical Chemistry and Laboratory Medicine, vol.46, issue.12, pp.1776-1783, 2008.
DOI : 10.1007/s11102-007-0032-z

J. Janssen, The introduction of the IDS-iSYS total IGF-1 assay may have farreaching consequences for diagnosis and treatment of GH deficiency, J Clin Endocrinol Metab, vol.100, pp.309-316, 2015.

G. Brabant and H. Wallaschofski, Normal levels of serum IGF-I: determinants and validity of current reference ranges, Pituitary, vol.60, issue.1, pp.129-133, 2007.
DOI : 10.1007/BF03339990

R. Junnila, C. Strasburger, and M. Bidlingmaier, Pitfalls of Insulin-like Growth Factor-I and Growth Hormone Assays, Endocrinology and Metabolism Clinics of North America, vol.44, issue.1, pp.27-34, 2015.
DOI : 10.1016/j.ecl.2014.10.003

P. Chanson, A. Arnoux, M. Mavromati, S. Brailly-tabard, C. Massart et al., Reference Values for IGF-I Serum Concentrations: Comparison of Six Immunoassays, The Journal of Clinical Endocrinology & Metabolism, vol.101, issue.9, pp.3450-3458, 2016.
DOI : 10.1210/jc.2016-1257
URL : https://hal.archives-ouvertes.fr/hal-01380421

S. Melmed and . Acromegaly, The Pituitary, p.16

J. Fermanian, Measuring agreement between 2 observers: a quantitative case

J. Fermanian, Measurement of agreement between 2 judges. Qualitative cases], Rev Epidemiol Sante Publique, vol.32, pp.140-147, 1984.

M. Bidlingmaier, N. Friedrich, R. Emeny, J. Spranger, O. Wolthers et al., Reference Intervals for Insulin-like Growth Factor-1 (IGF-I) From Birth to Senescence: Results From a Multicenter Study Using a New Automated Chemiluminescence IGF-I Immunoassay Conforming to Recent International Recommendations, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.5, pp.1712-1721, 2014.
DOI : 10.1210/jc.2013-3059

D. Clemmons, IGF-I assays: current assay methodologies and their limitations, Pituitary, vol.19, issue.2, pp.121-128, 2007.
DOI : 10.1093/gerona/53A.3.M176

R. Kay, D. Halsall, A. Annamalai, N. Kandasamy, K. Taylor et al., A novel mass spectrometry-based method for determining insulin-like growth factor 1: assessment in a cohort of subjects with newly diagnosed acromegaly, Clinical Endocrinology, vol.1, issue.Suppl 1, pp.424-430, 2013.
DOI : 10.1002/dta.59

H. Ketha and R. Singh, Clinical assays for quantitation of insulin-like-growth-factor-1 (IGF1), Methods, vol.81, pp.93-98, 2015.
DOI : 10.1016/j.ymeth.2015.04.029